Advisory Alpha, LLC Arcellx, Inc. Transaction History
Advisory Alpha, LLC
- $3.54 Billion
- Q3 2025
A detailed history of Advisory Alpha, LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Advisory Alpha, LLC holds 3,000 shares of ACLX stock, worth $270,690. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,000Holding current value
$270,690% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding ACLX
# of Institutions
234Shares Held
49.2MCall Options Held
248KPut Options Held
888K-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$419 Million14.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.91MShares$353 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$338 Million20.45% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$317 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$274 Million4.37% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.95B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...